Introduction: The aim of this study was to evaluate the efficacy of a psychoeducational program (PEP) for weight control in patients who had experienced an increase of body weight during treatment with olanzapine. Methods: Eligible patients were randomised to the PEP (Group 1 ) or to no intervention (Group 2) and continued on olanzapine. After 12 weeks, the PEP was also started in Group 2 and continued in Group 1, up to week 24. Body weight was measured every month. Other measures included quality of life, and change in plasma glucose and lipids levels. Results: Patients in Group 1 (n = 15) had a mean weight loss of 3.6 kg at week 12 and 4.5 kg at week 24 (p < 0.01 at both times, p < 0.01 between groups at week 12), while those in Group 2 (n = 18) had no changes at week 12 and a significant weight loss at week 24 ( -3.6 kg from week 12, p < 0.01). Changes of BMI paralleled those of body weight. Quality of life (Q-LES-Q-SF categorisation) and functioning (GAF) significantly improved in the total population at endpoint (p < 0.01). No significant changes were observed in fasting glucose and lipid profile, while insulin levels significantly decreased from baseline to endpoint in both groups (p < 0.05). HOMA index and hepatic insulin sensitivity improved, too. Discussion: Patients with increased BMI during treatment with olanzapine experienced significant weight and BMI loss following a structured psychoeducational program. © Georg Thieme Verlag KG Stuttgart.

Mauri, M., Simoncini, M., Castrogiovanni, S., Iovieno, N., Cecconi, D., Dellagnello, G., et al. (2008). A Psychoeducational Program for Weight Loss in Patients who have Experienced Weight Gain during Antipsychotic Treatment with Olanzapine. PHARMACOPSYCHIATRY, 41(1), 17-23 [10.1055/s-2007-992148].

A Psychoeducational Program for Weight Loss in Patients who have Experienced Weight Gain during Antipsychotic Treatment with Olanzapine

FAGIOLINI, A.;
2008

Abstract

Introduction: The aim of this study was to evaluate the efficacy of a psychoeducational program (PEP) for weight control in patients who had experienced an increase of body weight during treatment with olanzapine. Methods: Eligible patients were randomised to the PEP (Group 1 ) or to no intervention (Group 2) and continued on olanzapine. After 12 weeks, the PEP was also started in Group 2 and continued in Group 1, up to week 24. Body weight was measured every month. Other measures included quality of life, and change in plasma glucose and lipids levels. Results: Patients in Group 1 (n = 15) had a mean weight loss of 3.6 kg at week 12 and 4.5 kg at week 24 (p < 0.01 at both times, p < 0.01 between groups at week 12), while those in Group 2 (n = 18) had no changes at week 12 and a significant weight loss at week 24 ( -3.6 kg from week 12, p < 0.01). Changes of BMI paralleled those of body weight. Quality of life (Q-LES-Q-SF categorisation) and functioning (GAF) significantly improved in the total population at endpoint (p < 0.01). No significant changes were observed in fasting glucose and lipid profile, while insulin levels significantly decreased from baseline to endpoint in both groups (p < 0.05). HOMA index and hepatic insulin sensitivity improved, too. Discussion: Patients with increased BMI during treatment with olanzapine experienced significant weight and BMI loss following a structured psychoeducational program. © Georg Thieme Verlag KG Stuttgart.
Mauri, M., Simoncini, M., Castrogiovanni, S., Iovieno, N., Cecconi, D., Dellagnello, G., et al. (2008). A Psychoeducational Program for Weight Loss in Patients who have Experienced Weight Gain during Antipsychotic Treatment with Olanzapine. PHARMACOPSYCHIATRY, 41(1), 17-23 [10.1055/s-2007-992148].
File in questo prodotto:
File Dimensione Formato  
A_Psychoeducational_Program_for_Weight_Loss_in_Patients_who_have_Experienced_Weight_Gain_during_Antipsychotic_Treatment_with_Olanzapine.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 148.96 kB
Formato Adobe PDF
148.96 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/12147
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo